Free Trial

Anpario (LON:ANP) Announces Earnings Results

Anpario logo with Consumer Defensive background

Key Points

  • Anpario reported earnings of GBX 16.87 earnings per share for the quarter, with a return on equity of 8.74% and a net margin of 9.23%.
  • The stock has a current price of GBX 502.80 and has seen a trading range between GBX 286 and GBX 510 over the past year.
  • Shore Capital reiterated a "house stock" rating and Anpario currently has a consensus rating of "Buy" with a target price of GBX 435.
  • Interested in Anpario? Here are five stocks we like better.

Anpario (LON:ANP - Get Free Report) announced its quarterly earnings data on Wednesday. The company reported GBX 16.87 EPS for the quarter, Digital Look Earnings reports. Anpario had a net margin of 9.23% and a return on equity of 8.74%.

Anpario Stock Performance

LON:ANP traded up GBX 2.50 during trading hours on Tuesday, reaching GBX 490. 32,208 shares of the company's stock were exchanged, compared to its average volume of 40,773. The firm has a market capitalization of £83.04 million, a price-to-earnings ratio of 2,006.55 and a beta of 0.58. The company has a 50-day moving average of GBX 409.51 and a 200 day moving average of GBX 413.73. The company has a quick ratio of 5.16, a current ratio of 6.15 and a debt-to-equity ratio of 0.10. Anpario has a 1-year low of GBX 286 and a 1-year high of GBX 510.

Wall Street Analyst Weigh In

Separately, Shore Capital reissued a "house stock" rating on shares of Anpario in a research report on Wednesday, September 10th. Two investment analysts have rated the stock with a Buy rating, According to MarketBeat.com, the stock currently has an average rating of "Buy" and a consensus target price of GBX 435.

Read Our Latest Analysis on Anpario

About Anpario

(Get Free Report)

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.

Featured Stories

Should You Invest $1,000 in Anpario Right Now?

Before you consider Anpario, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anpario wasn't on the list.

While Anpario currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.